Articles from GBI Bio

XenImmune and GBI Bio to Assess SmartScale for AGF Production to Target Tumors
SmartScale platform aligns with the FDA's Operation TrialBlazer initiative
By GBI Bio · Via GlobeNewswire · November 3, 2026